PHGR: High-Impact HIV Prevention

PHGR: High-Impact HIV Prevention

Public Health Grand Rounds

On This Page

• Presentation
• Presented By
• Facilitated By
• Additional Resources

High-Impact HIV Prevention

This session of Grand Rounds explored High-Impact HIV Prevention in the United States.  Because HIV incidence is stable and effective treatment exists to prevent illness and death, a growing number of persons—over 1.1 million--are living with HIV.  The growing number with the potential to transmit HIV presents a challenge for prevention.  At the same time, recent scientific breakthroughs in treatment, prevention, and monitoring disease have equipped us with an unprecedented number of effective tools to prevent infection.  High Impact HIV Prevention seeks the most effective distribution of limited resources, considering the effectiveness and cost of prevention interventions and the feasibility of full-scale implementation.
New directions in monitoring the burden of HIV and resource allocation modeling of HIV prevention interventions were presented as well as the White House’s ongoing implementation of the National HIV/AIDS Strategy to improve HIV prevention and care.
Tentative future Grand Rounds topics include Explaining the Unexplained in Clinical Infectious Diseases, Injection Safety and Disability.

Presentation

• Watch the presentation on YouTube
• Video (403mb, total time:1:04:45)
• Science of Optimizing HIV Prevention (3.28mb)

Presented By

Jonathan Mermin, MD, MPH
Director, Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
“Science of Optimizing HIV Prevention”
Irene Hall, PhD, MPH, FACE
Chief, HIV Incidence and Case Surveillance Branch, Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
“HIV Surveillance in Action”
Stephanie Sansom, PhD, MPP, MPH
Commander, U.S. Public Health Service
Lead, Prevention Economics Team
Quantitative Sciences and Data Management Branch, Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
“Modeling to Identify Optimal Allocation of HIV Prevention Resources in a City Health Department”
Grant Colfax, MD
Director, Office of National AIDS Policy
The White House
“Overview of the National HIV/AIDS Strategy Implementation”

Facilitated By

Tanja Popovic, MD, PhD, Scientific Director, Public Health Grand Rounds
John Iskander, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds
Susan Laird, MSN, RN, Communications Manager, Public Health Grand Rounds

Additional Resources

• HIV in the United States
• The Future of HIV Prevention in the United States